Summarized chimerism data of CA mice and control mice in the absence of cytoreductive conditioning and with reduced-intensity myeloablation
Genotype . | n . | Conditioning . | . | Final RBC chimerism . | HSPC chimerism . | Granulocyte chimerism . |
---|---|---|---|---|---|---|
α2α1/α2α1, γHPFHβ0/γHPFHβ0 | 12 | anti-CD122, Diprotin A | Mean | 87.9* | 5.2 | 4.8 |
Range | 59.3-98.9 | 0.5-15.7 | 0.8-10.6 | |||
SEM | 3.67 | 1.28 | 1.07 | |||
α2α1/α2α1, γHPFHβ0/+ | 7 | Mean | 1.2* | ND | 1.7 | |
Range | 0.0-4.2 | 0.0-6.0 | ||||
SEM | 0.63 | 0.87 | ||||
α2α1/α2α1, +/+ | 5 | Mean | 2.6* | ND | 1.5 | |
Range | 0.0-6.1 | 0.0-6.4 | ||||
SEM | 1.35 | 1.24 | ||||
α2α1/α2α1, γHPFHβ0/γHPFHβ0 | 5 | 400 rad | Mean | 99.7 | 57.7 | 59.5 |
Range | 98.8-99.9 | 15.1-97.1 | 18.8-83.7 | |||
SEM | 0.22 | 16.84 | 12.91 |
Genotype . | n . | Conditioning . | . | Final RBC chimerism . | HSPC chimerism . | Granulocyte chimerism . |
---|---|---|---|---|---|---|
α2α1/α2α1, γHPFHβ0/γHPFHβ0 | 12 | anti-CD122, Diprotin A | Mean | 87.9* | 5.2 | 4.8 |
Range | 59.3-98.9 | 0.5-15.7 | 0.8-10.6 | |||
SEM | 3.67 | 1.28 | 1.07 | |||
α2α1/α2α1, γHPFHβ0/+ | 7 | Mean | 1.2* | ND | 1.7 | |
Range | 0.0-4.2 | 0.0-6.0 | ||||
SEM | 0.63 | 0.87 | ||||
α2α1/α2α1, +/+ | 5 | Mean | 2.6* | ND | 1.5 | |
Range | 0.0-6.1 | 0.0-6.4 | ||||
SEM | 1.35 | 1.24 | ||||
α2α1/α2α1, γHPFHβ0/γHPFHβ0 | 5 | 400 rad | Mean | 99.7 | 57.7 | 59.5 |
Range | 98.8-99.9 | 15.1-97.1 | 18.8-83.7 | |||
SEM | 0.22 | 16.84 | 12.91 |
Chimerism data were collected after 150 d upon euthanasia of recipients. Chimerism values represent percentage of GFP+ donor cells among RBCs, HSPCs (Lin–Sca1+cKit+), and granulocytes (Gr1+). Means, ranges, and SEMs are shown. RBC chimerism was significantly different between CA mice and control mice as determined by 1-way analysis of variance. By the same test, there was no statistically significant difference between granulocyte chimerism levels within the groups undergoing noncytoreductive conditioning.
ND, not determined.
P ≤ .00001.